Highlights of the financial year 2020

Net sales
+1.3%
Currency-adjusted net sales growth in 2020
Net sales development
2011–2020
2011–2020
(in CHF million)

EBIT, EBITDA, Net income,
Earnings per share (EPS)
2018–2020
Earnings per share (EPS)
2018–2020
(in CHF million)(EPS: in CHF)
* Adjusted for costs in connection with the Sanitec acquisition and integration (EBITDA 2018 not adjusted)
Net income development
2011–2020
2011–2020
(in CHF million)
* Adjusted for costs in connection with the Sanitec acquisition and integration

Free cashflow
(in CHF)
717 million
+11.4% versus prior year
Operating cashflow margin
(EBITDA margin)
(EBITDA margin)
31.0%
+170 basis points higher than prior year

R&D expenditures
(in CHF)
75 million
2.5% of net sales
Investments in property, plant and equipment and intangible assets
(in CHF)
(in CHF)
150 million
-10.2% versus prior year

Currency effects in net sales
(in CHF)
-136 million
Currency effects in EBIT
(in CHF)
(in CHF)